Demoralized FDA staff say a misleading announcement last week on convalescent plasma undermined scientists’ credibility and turned the agency into a prop in the president’s reelection campaign, the Washington Post reports.
Many worry such incidents erode public trust before regulators make a sensitive and potentially fraught decision — deciding when a coronavirus vaccine is safe and effective.
Save to Favorites